Pharmaceuticals

China Myasthenia Gravis Drugs Market Research Report 2017

  • QYR1043772
  • 110 Pages
  • March 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Myasthenia Gravis Drugs

Revenue, means the sales value of Myasthenia Gravis Drugs

This report studies Myasthenia Gravis Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering

Flamel Technologies

F. Hoffmann-La Roche

Grifols

Pfizer

Shire

Novartis

Valeant Pharmaceuticals

Alexion Pharmaceuticals

Catalyst Pharmaceuticals

CSL

Curavac

Cytokinetics

Galencia

GlaxoSmithKline

Lupin Pharmaceuticals

Mitsubishi Tanabe Pharma

Market Segment by Regions (provinces), covering

South China

East China

Southwest China

Northeast China

North China

Central China

Northwest China

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into

Anticholinesterases

Immunosuppressants

Intravenous Immune Globulins

Split by Application, this report focuses on consumption, market share and growth rate of Myasthenia Gravis Drugs in each application, can be divided into

Hospitals

Clinics

Table of Contents

China Myasthenia Gravis Drugs Market Research Report 2017

1 Myasthenia Gravis Drugs Market Overview

1.1 Product Overview and Scope of Myasthenia Gravis Drugs

1.2 Myasthenia Gravis Drugs Segment by Type

1.2.1 China Production Market Share of Myasthenia Gravis Drugs Type in 2015

1.2.2 Anticholinesterases

1.2.3 Immunosuppressants

1.2.4 Intravenous Immune Globulins

1.3 Applications of Myasthenia Gravis Drugs

1.3.1 Myasthenia Gravis Drugs Consumption Market Share by Application in 2015

1.3.2 Hospitals

1.3.3 Clinics

1.4 China Market Size (Value) of Myasthenia Gravis Drugs (2012-2022)

1.5 China Myasthenia Gravis Drugs Status and Outlook

1.6 Government Policies

2 China Myasthenia Gravis Drugs Market Competition by Manufacturers

2.1 China Myasthenia Gravis Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)

2.2 China Myasthenia Gravis Drugs Revenue and Share by Manufacturers (2015 and 2016)

2.3 China Myasthenia Gravis Drugs Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Myasthenia Gravis Drugs Manufacturing Base Distribution, Sales Area, Product Type

2.5 Myasthenia Gravis Drugs Market Competitive Situation and Trends

2.5.1 Myasthenia Gravis Drugs Market Concentration Rate

2.5.2 Myasthenia Gravis Drugs Market Share of Top 3 and Top 5 Manufacturers

3 China Myasthenia Gravis Drugs Manufacturers Profiles/Analysis

3.1 Flamel Technologies

3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.1.2 Myasthenia Gravis Drugs Product Type, Application and Specification

3.1.2.1 Product A

3.1.2.2 Product B

3.1.3 Flamel Technologies Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.1.4 Main Business/Business Overview

3.2 F. Hoffmann-La Roche

3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.2.2 Myasthenia Gravis Drugs Product Type, Application and Specification

3.2.2.1 Product A

3.2.2.2 Product B

3.2.3 F. Hoffmann-La Roche Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.2.4 Main Business/Business Overview

3.3 Grifols

3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.3.2 Myasthenia Gravis Drugs Product Type, Application and Specification

3.3.2.1 Product A

3.3.2.2 Product B

3.3.3 Grifols Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.3.4 Main Business/Business Overview

3.4 Pfizer

3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.4.2 Myasthenia Gravis Drugs Product Type, Application and Specification

3.4.2.1 Product A

3.4.2.2 Product B

3.4.3 Pfizer Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.4.4 Main Business/Business Overview

3.5 Shire

3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.5.2 Myasthenia Gravis Drugs Product Type, Application and Specification

3.5.2.1 Product A

3.5.2.2 Product B

3.5.3 Shire Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.5.4 Main Business/Business Overview

3.6 Novartis

3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.6.2 Myasthenia Gravis Drugs Product Type, Application and Specification

3.6.2.1 Product A

3.6.2.2 Product B

3.6.3 Novartis Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.6.4 Main Business/Business Overview

3.7 Valeant Pharmaceuticals

3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.7.2 Myasthenia Gravis Drugs Product Type, Application and Specification

3.7.2.1 Product A

3.7.2.2 Product B

3.7.3 Valeant Pharmaceuticals Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.7.4 Main Business/Business Overview

3.8 Alexion Pharmaceuticals

3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.8.2 Myasthenia Gravis Drugs Product Type, Application and Specification

3.8.2.1 Product A

3.8.2.2 Product B

3.8.3 Alexion Pharmaceuticals Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.8.4 Main Business/Business Overview

3.9 Catalyst Pharmaceuticals

3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.9.2 Myasthenia Gravis Drugs Product Type, Application and Specification

3.9.2.1 Product A

3.9.2.2 Product B

3.9.3 Catalyst Pharmaceuticals Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.9.4 Main Business/Business Overview

3.10 CSL

3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.10.2 Myasthenia Gravis Drugs Product Type, Application and Specification

3.10.2.1 Product A

3.10.2.2 Product B

3.10.3 CSL Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.10.4 Main Business/Business Overview

3.11 Curavac

3.12 Cytokinetics

3.13 Galencia

3.14 GlaxoSmithKline

3.15 Lupin Pharmaceuticals

3.16 Mitsubishi Tanabe Pharma

4 China Myasthenia Gravis Drugs Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)

4.1 China Myasthenia Gravis Drugs Capacity, Production and Growth (2012-2017)

4.2 China Myasthenia Gravis Drugs Revenue and Growth (2012-2017)

4.3 China Myasthenia Gravis Drugs Production, Consumption, Export and Import (2012-2017)

5 China Myasthenia Gravis Drugs Production, Revenue (Value), Price Trend by Type

5.1 China Myasthenia Gravis Drugs Production and Market Share by Type (2012-2017)

5.2 China Myasthenia Gravis Drugs Revenue and Market Share by Type (2012-2017)

5.3 China Myasthenia Gravis Drugs Price by Type (2012-2017)

5.4 China Myasthenia Gravis Drugs Production Growth by Type (2012-2017)

6 China Myasthenia Gravis Drugs Market Analysis by Application

6.1 China Myasthenia Gravis Drugs Consumption and Market Share by Application (2012-2017)

6.2 China Myasthenia Gravis Drugs Consumption Growth Rate by Application (2012-2017)

6.3 Market Drivers and Opportunities

6.3.1 Potential Application

6.3.2 Emerging Markets/Countries

7 ChinaMyasthenia Gravis Drugs Market Analysis by Regions (Provinces)

7.1 China Myasthenia Gravis Drugs Production, Production Value and Price by Regions (Provinces)(2012-2017)

7.1.1 China Myasthenia Gravis Drugs Production and Market Share by Regions (Provinces)(2012-2017)

7.1.2 China Myasthenia Gravis Drugs Production Value and Market Share by Regions (Provinces)(2012-2017)

7.1.3 China Myasthenia Gravis Drugs Sales Price by Regions (Provinces)(2012-2017)

7.2 China Myasthenia Gravis Drugs Consumption by Regions (Provinces)(2012-2017)

7.3 China Myasthenia Gravis Drugs Production, Consumption, Export and Import (2012-2017)

8 Myasthenia Gravis Drugs Manufacturing Cost Analysis

8.1 Myasthenia Gravis Drugs Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Myasthenia Gravis Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Myasthenia Gravis Drugs Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Myasthenia Gravis Drugs Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 China Myasthenia Gravis Drugs Market Forecast (2017-2022)

12.1 China Myasthenia Gravis Drugs Capacity, Production, Revenue Forecast (2017-2022)

12.2 China Myasthenia Gravis Drugs Production, Import, Export and Consumption Forecast (2017-2022)

12.3 China Myasthenia Gravis Drugs Production Forecast by Type (2017-2022)

12.4 China Myasthenia Gravis Drugs Consumption Forecast by Application (2017-2022)

12.5 China Myasthenia Gravis Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

12.5.1 China Myasthenia Gravis Drugs Production Forecast by Regions (Provinces)(2017-2022)

12.5.2 China Myasthenia Gravis Drugs Consumption Forecast by Regions (Provinces)(2017-2022)

12.5.3 China Myasthenia Gravis Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

12.6 Myasthenia Gravis Drugs Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Myasthenia Gravis Drugs

Figure China Production Market Share of Myasthenia Gravis Drugs by Type in 2015

Figure Product Picture of Anticholinesterases

Table Major Manufacturers of Anticholinesterases

Figure Product Picture of Immunosuppressants

Table Major Manufacturers of Immunosuppressants

Figure Product Picture of Intravenous Immune Globulins

Table Major Manufacturers of Intravenous Immune Globulins

Table Myasthenia Gravis Drugs Consumption Market Share by Application in 2015

Figure Hospitals Examples

Figure Clinics Examples

Figure China Myasthenia Gravis Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Table China Myasthenia Gravis Drugs Capacity of Key Manufacturers (2015 and 2016)

Table China Myasthenia Gravis Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)

Figure China Myasthenia Gravis Drugs Capacity of Key Manufacturers in 2015

Figure China Myasthenia Gravis Drugs Capacity of Key Manufacturers in 2016

Table China Myasthenia Gravis Drugs Production of Key Manufacturers (2015 and 2016)

Table China Myasthenia Gravis Drugs Production Share by Manufacturers (2015 and 2016)

Figure 2015 Myasthenia Gravis Drugs Production Share by Manufacturers

Figure 2016 Myasthenia Gravis Drugs Production Share by Manufacturers

Table China Myasthenia Gravis Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)

Table China Myasthenia Gravis Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 China Myasthenia Gravis Drugs Revenue Share by Manufacturers

Table 2016 China Myasthenia Gravis Drugs Revenue Share by Manufacturers

Table China Market Myasthenia Gravis Drugs Average Price of Key Manufacturers (2015 and 2016)

Figure China Market Myasthenia Gravis Drugs Average Price of Key Manufacturers in 2015

Table Manufacturers Myasthenia Gravis Drugs Manufacturing Base Distribution and Sales Area

Table Manufacturers Myasthenia Gravis Drugs Product Type

Figure Myasthenia Gravis Drugs Market Share of Top 3 Manufacturers

Figure Myasthenia Gravis Drugs Market Share of Top 5 Manufacturers

Table Flamel Technologies Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Flamel Technologies Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Flamel Technologies Myasthenia Gravis Drugs Market Share (2012-2017)

Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table F. Hoffmann-La Roche Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure F. Hoffmann-La Roche Myasthenia Gravis Drugs Market Share (2012-2017)

Table Grifols Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Grifols Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Grifols Myasthenia Gravis Drugs Market Share (2012-2017)

Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Pfizer Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Pfizer Myasthenia Gravis Drugs Market Share (2012-2017)

Table Shire Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Shire Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Shire Myasthenia Gravis Drugs Market Share (2012-2017)

Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novartis Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Novartis Myasthenia Gravis Drugs Market Share (2012-2017)

Table Valeant Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Valeant Pharmaceuticals Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Valeant Pharmaceuticals Myasthenia Gravis Drugs Market Share (2012-2017)

Table Alexion Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Alexion Pharmaceuticals Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Alexion Pharmaceuticals Myasthenia Gravis Drugs Market Share (2012-2017)

Table Catalyst Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Catalyst Pharmaceuticals Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Catalyst Pharmaceuticals Myasthenia Gravis Drugs Market Share (2012-2017)

Table CSL Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table CSL Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure CSL Myasthenia Gravis Drugs Market Share (2012-2017)

Table Curavac Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Cytokinetics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Galencia Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Lupin Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors

Figure China Myasthenia Gravis Drugs Capacity, Production and Growth (2012-2017)

Figure China Myasthenia Gravis Drugs Revenue (Million USD) and Growth (2012-2017)

Table China Myasthenia Gravis Drugs Production, Consumption, Export and Import (2012-2017)

Table China Myasthenia Gravis Drugs Production by Type (2012-2017)

Table China Myasthenia Gravis Drugs Production Share by Type (2012-2017)

Figure Production Market Share of Myasthenia Gravis Drugs by Type (2012-2017)

Figure 2015 Production Market Share of Myasthenia Gravis Drugs by Type

Table China Myasthenia Gravis Drugs Revenue by Type (2012-2017)

Table China Myasthenia Gravis Drugs Revenue Share by Type (2012-2017)

Figure Production Revenue Share of Myasthenia Gravis Drugs by Type (2012-2017)

Figure 2015 Revenue Market Share of Myasthenia Gravis Drugs by Type

Table China Myasthenia Gravis Drugs Price by Type (2012-2017)

Figure China Myasthenia Gravis Drugs Production Growth by Type (2012-2017)

Table China Myasthenia Gravis Drugs Consumption by Application (2012-2017)

Table China Myasthenia Gravis Drugs Consumption Market Share by Application (2012-2017)

Figure China Myasthenia Gravis Drugs Consumption Market Share by Application in 2015

Table China Myasthenia Gravis Drugs Consumption Growth Rate by Application (2012-2017)

Figure China Myasthenia Gravis Drugs Consumption Growth Rate by Application (2012-2017)

Table China Myasthenia Gravis Drugs Production by Regions (Provinces)(2012-2017)

Table China Myasthenia Gravis Drugs Production Market Share by Regions (Provinces)(2012-2017)

Table China Myasthenia Gravis Drugs Production Value by Regions (Provinces)(2012-2017)

Table China Myasthenia Gravis Drugs Production Value Market Share by Regions (Provinces)(2012-2017)

Table China Myasthenia Gravis Drugs Sales Price by Regions (Provinces)(2012-2017)

Table China Myasthenia Gravis Drugs Consumption by Regions (Provinces)(2012-2017)

Table China Myasthenia Gravis Drugs Consumption Market Share by Regions (Provinces)(2012-2017)

Table China Myasthenia Gravis Drugs Production, Consumption, Export and Import (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Myasthenia Gravis Drugs

Figure Manufacturing Process Analysis of Myasthenia Gravis Drugs

Figure Myasthenia Gravis Drugs Industrial Chain Analysis

Table Raw Materials Sources of Myasthenia Gravis Drugs Major Manufacturers in 2015

Table Major Buyers of Myasthenia Gravis Drugs

Table Distributors/Traders List

Figure China Myasthenia Gravis Drugs Capacity, Production and Growth Rate Forecast (2017-2022)

Figure China Myasthenia Gravis Drugs Revenue and Growth Rate Forecast (2017-2022)

Table China Myasthenia Gravis Drugs Production, Import, Export and Consumption Forecast (2017-2022)

Table China Myasthenia Gravis Drugs Production Forecast by Type (2017-2022)

Table China Myasthenia Gravis Drugs Consumption Forecast by Application (2017-2022)

Table China Myasthenia Gravis Drugs Production Forecast by Regions (Provinces)(2017-2022)

Table China Myasthenia Gravis Drugs Consumption Forecast by Regions (Provinces)(2017-2022)

Table China Myasthenia Gravis Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370